Arterial and venous pharmacokinetics of ropivacaine with and without epinephrine after thoracic paravertebral block.

Background: Animal and volunteer studies indicate that ropivacaine is associated with less neurologic and cardiac toxicity than bupivacaine. Ropivacaine may offer advantages when used for thoracic paravertebral block. This study was designed to describe the pharmacokinetics of ropivacaine after thor...

Descripción completa

Detalles Bibliográficos
Publicado en:Anesthesiology Vol. 103; no. 4; pp. 704 - 712
Autores principales: Karmakar MK, Ho AM, Law BK, Wong ASY, Shafer SL, Gin T, Karmakar, Manoj K, Ho, Anthony M-H, Law, Bonita K, Wong, April S Y, Shafer, Steven L, Gin, Tony
Formato: clinical trial equations & formulas research tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins Oct2005
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106104937&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106104937
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00033022
        1V8
      jtl: Anesthesiology
      issn: 00033022
      maglogo: N
    pubinfo:
      dt: Oct2005
      vid: 103
      iid: 4
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        106104937
        106104937
        NLM16192762
        2009580292
        NLM16192762
        106104937
      ppf: 704
      ppct: 8
      formats:
      tig:
        atl: Arterial and venous pharmacokinetics of ropivacaine with and without epinephrine after thoracic paravertebral block.
      aug:
        au:
          Karmakar MK
          Ho AM
          Law BK
          Wong ASY
          Shafer SL
          Gin T
          Karmakar, Manoj K
          Ho, Anthony M-H
          Law, Bonita K
          Wong, April S Y
          Shafer, Steven L
          Gin, Tony
        affil: Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital
      sug:
        subj:
          Anesthetics, Local Pharmacokinetics
          Epinephrine Pharmacodynamics
          Nerve Block
          Absorption
          Adult
          Amides Pharmacokinetics
          Breast Surgery
          Clinical Trials
          Data Analysis Software
          Descriptive Statistics
          Drug Interactions
          Female
          Fisher's Exact Test
          Hong Kong
          Mann-Whitney U Test
          Middle Age
          Post Hoc Analysis
          Random Assignment
          T-Tests
          Thoracic Vertebrae
          Wilcoxon Rank Sum Test
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
      ab: Background: Animal and volunteer studies indicate that ropivacaine is associated with less neurologic and cardiac toxicity than bupivacaine. Ropivacaine may offer advantages when used for thoracic paravertebral block. This study was designed to describe the pharmacokinetics of ropivacaine after thoracic paravertebral block.Methods: Twenty female patients undergoing elective unilateral breast surgery were randomly assigned to receive a single bolus thoracic paravertebral injection of 2 mg/kg ropivacaine, with or without 5 mug/ml epinephrine. Simultaneous arterial and venous blood samples were obtained for plasma ropivacaine assay. Data were analyzed with NONMEM, using two possible absorption models: conventional first-order absorption and absorption following the inverse gaussian density function.Results: Epinephrine reduced the peak plasma concentrations and delayed the time of peak concentration of ropivacaine in both the arterial and venous blood. The time course of drug input into the systemic circulation was best described by two inverse gaussian density functions. The median bioavailability of the rapid component was approximately 20% higher when epinephrine was not used. The mean absorption times were 7.8 min for the rapid absorption phase and 697 min for the slow absorption phase, with wide dispersion of the absorption function for the acute phase. The half-time of arterial-venous equilibration was 1.5 min.Conclusion: The absorption of ropivacaine after thoracic paravertebral block is described by rapid and slow absorption phases. The rapid phase approximates the speed of intravenous administration and accounts for nearly half of ropivacaine absorption. The addition of 5 mug/ml epinephrine to ropivacaine significantly delays its systemic absorption and reduces the peak plasma concentration.
      pubtype: Academic Journal
      doctype:
        clinical trial
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N